AQST News and Press, Aquestive Therapeutics Inc. From 11/04/20

Aquestive Therapeutics (AQST): Q3 GAAP EPS of -$0.49 misses by $0.04.Revenue of $8.3M (-33.1% Y/Y) misses by $0.42M.FY20 guidance: Total revenues of ~$42M-$46M vs consensus of $47.3M; Non-GAAP adjusted gross margins of ~70%-75%; Non-GAAP adjusted EBITDA loss of ~$38M-$42M; Cash burn of ~...

Sympazan® (clobazam) continues to meet key performance metrics and market penetration FDA Type A meeting for Libervant™ (diazepam) Buccal Film scheduled for November 12, 2020 Completed dosing in Phase 1 Pharmacokinetic (PK) trial for AQST-108 (epinephrine) Execut...

Beasley Broadcast Group (BBGI) +54% on Q3 results.Alaska Communications Systems Group (ALSK) +56% after announcing agreement to be acquired by Macquarie Capital and GCM Grosvenor for $3.0 per share.JAKKS Pacific (JAKK) +18% on Q3 results.trivago N.V. (TRVG) +15%....

Aquestive Therapeutics (AQST) +6.3% PM, entered a royalty monetization agreement with an affiliate of Marathon Asset Management, a leading global investment firm, leading to proceeds of up to $125M.As per agreement terms, Aquestive will receive $40M at closing and is eligible to receive ...

Receives $ 4 0 million of proceeds at closing , with potential $ 2 5 million of additional proceeds by mid-2022 Reduces outstanding debt to $5 1.5 million WARREN, N.J., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics...

WARREN, N.J., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that it will repo...

Recent disapproval from FDA regarding Libervant Buccal Film has seen investors react sourly over the last 2 weeks. Investors have punished the company, with the stock giving away ~-47% in returns over this period. Recent history shows the market can see the upside in Aquestive, an...

Blueprint gets European Union nod for Ayvakyt. Aquestive receives CRL for seizure clusters treatment Libervant. PMV Pharma makes impressive IPO debut, stock soars. For further details see: Blueprint European Approval, And Other News: The Good, Bad And Ugly Of Biopharma ...

Gainers: Oxbridge Re (OXBR) +248%.Ambow Education (AMBO) +103%.Perceptron (PRCP) +66%.Ashford Hospitality Trust (AHT) +35%.Genfit (GNFT) +30%.Westwater Resources (WWR) +27%.American Shared Hospital Services (AMS) +24%.The Peck Company (PECK) +24%.Emerald Holding (EEX) +22%.Fly ...

Gainers: Genfit (GNFT) +35%, Trxade Group (MEDS) +20%, Celldex Therapeutics (CLDX) +15%, EDAP TMS (EDAP) +13%, Kaleido Biosciences (KLDO) +8%.Losers: Abeona Therapeutics (ABEO) -33%, Aquestive Therapeutics (AQST) -35%, Mallinckrodt (MNK)&...